Novel regulator of mitochondrial cell death reveals a promising target for cancer therapy

Researchers at The Wistar Institute have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. They also found that expression of MFF is regulated by Myc, a ubiquitous mediator of cell proliferation that contributes to development of many cancer types. These results were published online in […]

Continue reading »

Diattenuation imaging—a promising imaging technique for brain research

A new imaging method provides structural information about brain tissue that was previously difficult to access. Diattenuation Imaging (DI), developed by scientists at Forschungszentrum Jülich and the University of Groningen, allows researchers to differentiate regions with many thin nerve fibres from regions with few thick nerve fibres. With current imaging methods, these tissue types cannot easily be distinguished. The DI […]

Continue reading »

First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple

A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary […]

Continue reading »